Surgery is not right for everyone
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss
(Low Wangs views do not represent those of the FDA or the FDA Endocrinologic and Metabolic Drugs Advisory Committee.) How much weight can people lose with retatrutide
Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia
A Conceptual Model of Food Cue Reactivity - PMC - PubMed Central, accessed April 22, 2025, GLP1 receptor agonists for the treatment of obesity: Role as a promising approach, accessed April 22, 2025, GLP-1 and the Neurobiology of Eating Control: Recent Advances - Oxford Academic, accessed April 22, 2025, pmc.ncbi.nlm.nih.gov, accessed April 22, 2025, Taking a GLP-1
GLP-1 receptor agonist use and risk of suicide death